Amplifying Scientific Innovation
Established in New York City, The Sophia Consulting Firm is a fully integrated marketing and communications firm with a specialty focus on oncology.
The firm partners with US and non-US emerging and established life science and healthcare technology companies to amplify scientific innovation, increase corporate visibility and attract investors.
The Sophia Consulting firm empowers client partners with integrated corporate and product communications support for clinical-stage assets through seamless provision of public relations, scientific communications, market research and strategic marketing services. These services are uniquely designed to evolve the corporate narrative for client partners and to identify white space opportunities.
Public Relations & Scientific Communications
Create and showcase credible scientific content rooted in data-driven research techniques to attract investors and increase corporate visibility via:
Market Research & Strategic Marketing
Engage with US and/or global senior executives, thought leaders, medical experts, hospital stakeholders and investors with the goal of increasing scientific credibility and stakeholder buy-in via:
In oncology and hematology, we have supported client partners with innovative work in:
The firm also provides consulting services in diverse therapeutic areas including:
We partner with world-class talent on a per-project basis with the goal of optimizing client satisfaction by right-sizing teams. Our partners include:
We hold ourselves to the highest standards and leverage relevant trends in order to develop actionable insights that stand the test of time. We are:
Season 1 Launching in June 2020 and will be hosted by Dr. Sophia Ononye-Onyia. Guests will include CEOs of emerging biotechnology companies who will share insights on scientific innovation prior to and following COVID19. Details are forthcoming!
Sign up to listen to our podcasts and read our latest blog posts and articles.
BS Honors, Biochemistry, BGSU
MPH, Public Health Administration, UTOLEDO
MBA, Healthcare Administration, UCONN
PhD, Medicinal Chemistry, UCONN
Advanced Business Certificate, Healthcare Finance, UCONN
Predoctoral Fellow, Pharmaceutical Science, AFPE
Postdoctoral Fellow, Medical Oncology, YALE
10+ peer-reviewed publications
Patent on epigenetic agents (WO2013192554A1)
Dr. Sophia Nnenna Ononye-Onyia is a Nigerian-American entrepreneur and life science strategist with interests in and passion for oncology, innovative drug development, digital health and value-based care. She recently founded The Sophia Consulting Firm where she leads the provision of fully integrated communication services for clients in the biotechnology, pharmaceutical, healthcare technology and consumer space.
A former Pfizer scientist and Yale-trained molecular oncologist, Sophia utilizes her multidisciplinary background (PhD, MPH, MBA) to advise clients in the life science industry on value communications and strategy planning for new drug launches with a specialty focus on oncology. She is trained in hematology and oncology with demonstrated experience in epigenetics, targeted therapies, combination therapies, checkpoint inhibitors, CAR T cell therapies and other cancer immunotherapies. Sophia also has broad therapeutic experience in rare diseases, women's health, pain management, and infectious diseases.
Key Advisor, BioSortia Pharmaceuticals
Board Member, BlueCloud by HealthCarePoint
Woman of The Week (WoW) Podcast Guest, PharmaVoice
Guest Contributor & Host, Pharmacy Podcast Network
Venture Partner, FundRx
Advisor, Harvard Biomedical Careers Science Program
Editorial Advisory Board Member, Cell & Gene
Panelist, MIT Technology Review
Contributor, Life Science Leader
Member, NYC Health Business Leaders
Mentor, Healthcare Businesswomen Association (HBA)
Spark Awardee, HBA
Certificate of Congressional Recognition, 30 Black Stars Award
Ms. Ellen Wingard is an early innovator in the field of leadership development and has for 30 years coached and advised CEOs and emerging leaders in health care, financial services, consumer goods, pharmaceuticals, technology and higher education. She is co-author of Enlightened Leadership: How Women are Transforming the Practice of Leadership. She is past Board Chair of World Pulse Media, an media channel linking 50,000 grassroots leaders across 190 countries, and a member of the Women’s Leadership Board at Harvard Kennedy School, where she engages with 150 top global corporate leaders on the latest practices in global talent development, gender inclusion and socially responsible business. She is part of the Executive Coaching pool of the Harvard Business School Executive Education Program and has been a commentator on career navigation and intergenerational mentoring to the Committee of 200, the Fletcher School International Business Program, Harvard Kennedy School, and NPR Marketplace. She has also served as a Mentor for the Impact Center a program affiliated with the Federal Leadership Program for distinguished public sector women leaders.
ALLIANCE MANAGEMENT STRATEGIST
Dr. James (Jim) Boyle is a co-founder and the Managing Director of the Yale Entrepreneurial Institute (YEI), a business/educational unit within Yale University that was formed with the mission of mentoring students with new venture ideas and that has expanded to include the development of faculty ventures. Prior to forming YEI, Jim was responsible within the Office of Cooperative Research (OCR) for the licensing and venture startup of a number of engineering-based technologies. Before joining OCR, he developed and actively managed the University’s largest corporate research alliance, managing a large array of both Yale and external scientists in bioimaging-based collaborations. Earlier, Jim co-founded and grew a predictive analytics consulting practice, providing both technical and pricing guidance on new product development to a wide array of Fortune 1000 companies in the scientific equipment industry. Jim began his entrepreneurial career while still a Yale graduate student, developing novel instruments for characterizing trace biomolecules with the support of the National Institutes of Health, and later commercializing these devices through a wide array of OEM partnerships as part of a Yale startup.
BIOTECH COMMERCIAL STRATEGIST
Ms. Loraine Upham's 30-year career in biotechnology and business ranges from basic research in the Molecular Genetics Research Laboratories at Eli Lilly and Company, to design and marketing of nuclear and fluorescence detection instrumentation at Packard BioScience (now Perkin Elmer), to process and business development at a proteomic start up, Prolexys. In 2005, she co-founded CureDM, Inc. together with two endocrinologists, to develop a novel diabetes treatment which she co-invented; as founding CEO of CureDM, she successfully obtained over $5M in financing and engineered partnerships to conduct basic research and establish the proof of concept for the diabetes drug which is now Phase II ready. Lori received a B.A. in Biology from University of Pennsylvania and an M.B.A from Arizona State University. She is a board member of numerous biotech companies and participates on the Investment Committee of the ABQid/CNM Ingenuity venture fund.
Dr. Sophia Ononye-Onyia recently interviewed Dr. Luis Alvarez, Director of Organ Manufacturing.
Born to be a leader, Dr. Sophia Ononye's intense curiosity, passion, energy, as well as her immigrant experience, give her a unique perspective as she strives to transform people's lives around the world.
Video courtesy of Face2Face Africa 30 Black Stars
Scientific animation video that shows how a type of white blood cell known as a macrophage engulfs and digests bacteria in a process called phagocytosis.
Dr. Sophia Ononye-Onyia will be attending the Xcelerating Life Sciences Philadelphia: Becoming the Cell & Gene Therapy Hub online forum and ...
Dr. Sophia Ononye-Onyia will attending the ONLINE Entrepreneurs Roundtable 142 with Jessica Peltz-Zatulove, MDC Ventures. Entrepreneurs Roun...
Dr. Sophia Ononye-Onyia will be attending the Patient Advocacy + event that was organized in collaboration with Swissnex, which is part of t...
Dr. Sophia Ononye-Onyia will be joining Choose New Jersey, The New Jersey Israeli Commission, BioJerusalem and BioNJ for a webinar that will...
Dr. Sophia Ononye-Onyia will be moderating a webinar for Israeli-based CollPlant Biotechnology featuring its Founder and Chief Scientist, Pr...
Brooklyn, New York, United States
08:00 am – 06:00 pm
08:00 am – 06:00 pm
08:00 am – 06:00 pm
08:00 am – 06:00 pm
08:00 am – 06:00 pm
Copyright © 2020 The Sophia Consulting Firm LLC - All Rights Reserved